Synthesis and evaluation of antimycobacterial activity of new benzimidazole aminoesters

European Journal of Medicinal Chemistry

Volumn 93, Issue , 2015, Pages 614-624

  Yoon, Yeong Keng ^a   Ali, Mohamed Ashraf ^a,b,c   Wei, Ang Chee ^a   Choon, Tan Soo ^a   Ismail, Rusli ^d  

^a INSTITUTE FOR RESEARCH IN MOLECULAR MEDICINE INFORMM   (Malaysia)

^b Alwar Pharmacy College   (India)

^c Sunrise University   (India)

^d UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Antimycobacterial; Azole; Benzimidazoles

Indexed keywords

AMIKACIN; ANTIMYCOBACTERIAL AGENT; BENZIMIDAZOLE DERIVATIVE; CYCLOSERINE; ETHAMBUTOL; ETHYL 2 [4 (TRIFLUOROMETHYL)PHENYL] 1 (2 MORPHOLINOETHYL) 1H BENZO[D]IMIDAZOLE 5 CARBOXYLATE; ISONIAZID; PYRIMETHAMINE; RIFAMPICIN; UNCLASSIFIED DRUG; BENZIMIDAZOLE; ESTER; TUBERCULOSTATIC AGENT;

ANTIBACTERIAL ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL VIABILITY; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; IC50; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; CHEMISTRY; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; SYNTHESIS;

ANTITUBERCULAR AGENTS; BENZIMIDAZOLES; CHEMISTRY TECHNIQUES, SYNTHETIC; ESTERS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS;

EID: 84924375326     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2013.06.025     Document Type: Article

References (25)

1. A.K. Dutt, W.W. Stead, Epidemiology and Host Factors: Tuberculosis and Nontuberculous Mycobacterial Infection, fourth ed., W.B. Saunders Company, Philadelphia, 1999, pp. 3-16.
2. World Health Organization, WHO Report 2011: Global Tuberculosis Control, WHO/HTM/TB/2011.16.
3. D.E. Snider Jr., W.L. Roper, The new tuberculosis, New England Journal of Medicine 326 (1992) 703-705.
4. J.B. Bass, L.S. Farer, P.C. Hopewell, R. O'Brien, R.F. Jacobs, F. Ruben, E. Dixie, J. Snider, G. Thornton, Treatment of tuberculosis and tuberculosis infection in adults and children, American Journal of Respiratory and Critical Care Medicine 149 (1994) 1359-1374.
5. M.A. Ali, M. Shaharyar, A.A. Siddiqui, Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives, European Journal of Medicinal Chemistry 42 (2007) 268-275.
6. U.S. Food and Drug Administration, Press Announcement. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333695.htm.
7. J. Avorn, Approval of a tuberculosis drug based on a paradoxical surrogate measure, The Journal of the American Medical Association 309 (2013) 1349-1350.
8. G. Komazin, R.G. Ptak, B.T. Emmer, L.B. Townsend, J.C. Drach, Resistance of human cytomegalovirus to D- and L-ribosyl benzimidazoles as a tool to identify potential targets for antiviral drugs, Nucleosides Nucleotides Nucleic Acids 22 (2003) 1725-1727.
9. M. Mader, A. de Dios, C. Shih, B.D. Anderson, Imidazolyl benzimidazoles and imidazo[4,5-b]pyridines as potent p38a MAP kinase inhibitors with excellent in vivo antiinflammatory properties, Bioorganic and Medicinal Chemistry Letters 18 (2008) 179-183.
10. A. Rao, A. Chimirri, E.D. Clercq, A.M. Monforte, P. Monforte, C. Pannecouque, M. Zappala, Synthesis and anti-HIV activity of 1-(2,6-difluorophenyl)-1H,3Hthiazolo[ 3,4-a]benzimidazole structurally-related 1,2-substituted benzimidazoles, Il Farmaco 57 (2002) 819-823.
11. B.E. Evans, K.E. Rittle, M.G. Bock, R.M. Dipardo, R.M. Freidinger, W.L. Whitter, G.F. Lundell, D.F. Veber, P.S. Anderson, Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists, Journal of Medicinal Chemistry 42 (1988) 2235-2246.
12. M. Pieroni, S.K. Tipparaju, S. Lun, Y. Song, A.W. Sturm, W.R. Bishai, A.P. Kozikowski, Pyrido[1,2-a]benzimidazole-based agents active against tuberculosis (TB), multidrug-resistant (MDR) TB and extensively drugresistant (XDR) TB, ChemMedChem 6 (2011) 334-342.
13. A. Lilienkampf, M. Pieroni, B. Wan, Y. Wang, S.G. Franzblau, A.P. Kozikowski, Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. A potent and selective series for further drug development, Journal of Medicinal Chemistry 53 (2010) 678-688.
14. N. Arumugam, A.S. Abdul Rahim, S. Abdul Hamid, H. Osman, Straightforward synthesis of novel 1-(2'-a-O-D-glucopyranosylethyl)2-arylbenzimidazoles, Molecules 17 (2012) 9887-9899.
15. H.T. Gomez, E.H. Nunez, I.L. Rivera, J.G. Alvarez, R. Cedillo-Rivera, R.M. Puc, R.A. Ramos, M.C. Rodriguez-Gutierrez, M.J. Chan-Bacab, G. Navarrete-Vazquez, Design, synthesis and in vitro antiprotozoal activity of benzimidazolepentamidine hybrids, Bioorganic and Medicinal Chemistry Letters 18 (2008) 3147-3151.
16. K.Y. Yeong, M.A. Ali, S.C. Tan, M. Hemamalini, H.K. Fun, Ethyl 1-[2-(morpholin-4-yl)ethyl]-2-[4-(trifluoromethyl)phenyl]-1H-benzimidazole-5-carboxylate, Acta Crystallographica E E67 (2011) o1215.
17. K.Y. Yeong, M.A. Ali, R. Ismail, M.M. Rosli, H.K. Fun, Ethyl 1-[2-(morpholin-4-yl)ethyl]-2-[4-(morpholin-4-yl)phenyl]-1H-1,3-benzimidazole-5-carboxylate, Acta Crystallographica E E67 (2011) o1772.
18. K.Y. Yeong, M.A. Ali, S.C. Tan, S.I.J. Asik, I.A. Razak, Ethyl 2-(4-nitrophenyl)-1-[3-(2-oxopyrrolidin-1-yl)propyl]-1H-benzimidazole-5-carboxylate, Acta Crystallographica E E68 (2012) o59.
19. K.Y. Yeong, M.A. Ali, C.W. Ang, S.I.J. Asik, I.A. Razak, Ethyl 2-(1,3-benzodioxol-5-yl)-1-[3-(2-oxopyrrolidin-1-yl)propyl]-1H-benzimidazole-5-carboxylate, Acta Crystallographica E E68 (2012) o471-o472.
20. W. Zeller, A.S. Kiselyov, J. Singh, Regiospeci fic synthesis of 3-alkyl-4-hydroxybenzimidazoles as intermediates for an expedient approach to potent EP3 receptor antagonists, Tetrahedron Letters 51 (2010) 1380-1382.
21. C. Gill, G. Jadhav, M. Shaikh, R. Kale, A. Ghawalkar, D. Nagargoje, M. Shiradkar, Clubbed [1,2,3] triazoles by fluorine benzimidazole: a novel approach to H37Rv inhibitors as a potential treatment for tuberculosis, Bioorganic and Medicinal Chemistry Letters 18 (2008) 6244-6247.
22. T. Roth, M.L. Morningstar, P.L. Boyer, S.H. Hughes, R.W. Buckheit, C.J. Michejda, Synthesis and biological activity of novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 2-Aryl-substituted benzimidazoles, Journal of Medicinal Chemistry 40 (1997) 4199-4207.
23. L. Collins, S.G. Franzblau, Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium, Antimicrobial Agents and Chemotherapy 41 (1997) 1004-1009.
24. R. Walia, M. Hedaitullah, S.F. Naaz, K. Iqbal, H.S. Lamba, Benzimidazole derivatives e an overview, International Journal of Research in Pharmacy and Chemistry 1 (2011) 565-574.
25. B. Shao, J. Huang, Q. Sun, K.J. Valenzano, L. Schmid, S. Nolan, 4-(2-Pyridyl) piperazine-1-benzimidazoles as potent TRPV1 antagonists, Bioorganic & Medicinal Chemistry Letters 15 (2005) 719-723.